Manager: Bo Wen
Location: NCRC, Bldg 520, 3400
The Pharmacokinetics (PK) core will study molecular ADME and Pharmacokinetics of drugs with three objectives:
1. To support preclinical pharmacokinetics, drug metabolism, and LC-MS analysis for lead compound selection and dose optimization in anticancer drug discovery and development
2. To support clinical pharmacokinetics (Non-GLP), LC-MS analysis, and dose optimization for clinical trials of anticancer drugs
3. To enhance joint grant applications, joint publications, joint patent applications with Cancer Center members in pharmacokinetic (PK) studies.